4//SEC Filing
Hopper Jonathan Mark 4
Accession 0001140361-25-007179
CIK 0000887359other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:05 PM ET
Size
8.5 KB
Accession
0001140361-25-007179
Insider Transaction Report
Form 4
Vericel CorpVCEL
Hopper Jonathan Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03+10,000→ 28,750 totalExercise: $18.00Exp: 2030-02-11→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2025-03-03$18.00/sh+10,000$180,000→ 76,101 total - Sale
Common Stock
2025-03-03$49.53/sh−10,000$495,300→ 66,101 total
Footnotes (3)
- [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024.
- [F3]These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001626325
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:05 PM ET
- Size
- 8.5 KB